Green Alpha Advisors, LLC Editas Medicine, Inc. Transaction History
Green Alpha Advisors, LLC
- $87.2 Million
- Q2 2025
A detailed history of Green Alpha Advisors, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 170,782 shares of EDIT stock, worth $377,428. This represents 0.43% of its overall portfolio holdings.
Number of Shares
170,782
Previous 183,903
7.13%
Holding current value
$377,428
Previous $229,000
63.76%
% of portfolio
0.43%
Previous 0.29%
Shares
19 transactions
Others Institutions Holding EDIT
# of Institutions
223Shares Held
47.8MCall Options Held
436KPut Options Held
324K-
Black Rock Inc. New York, NY7.78MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$15.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.66MShares$5.88 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.6MShares$5.75 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$4.34 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $152M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...